Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration

Antibodies validated for use with Bio-Rad’s Celselect Slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.

FXI Inhibitor Cuts Bleeds in Afib; COAPT Extends to Real World; AI Stroke Triage

People who were prone to needing dentures tended to also be at higher risk of cardiometabolic disease. (European Journal of Preventive Cardiology) Early real-world experience

September 20, 2023

2023 Nobel Prize in Medicine: Karikó, Weissman awarded prize for mRNA research

LONDON — Two pioneers of mRNA research — the technology that helped the world tame the virus behind the Covid-19 pandemic — won the 2023

October 2, 2023

BetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent | Psychedelic Invest

VANCOUVER, British Columbia, Aug. 27, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.